1.92
Bioharvest Sciences Inc stock is traded at $1.92, with a volume of 69,615.
It is down -4.00% in the last 24 hours and down -34.02% over the past month.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
See More
Previous Close:
$2.00
Open:
$2.06
24h Volume:
69,615
Relative Volume:
2.02
Market Cap:
$43.52M
Revenue:
$35.16M
Net Income/Loss:
$-11.44M
P/E Ratio:
-3.2209
EPS:
-0.5961
Net Cash Flow:
$-15.44M
1W Performance:
-28.89%
1M Performance:
-34.02%
6M Performance:
-65.78%
1Y Performance:
-75.54%
Bioharvest Sciences Inc Stock (BHST) Company Profile
Name
Bioharvest Sciences Inc
Sector
Industry
Phone
-
Address
-
Compare BHST vs JBS, KHC, GIS, HRL, MKC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BHST
Bioharvest Sciences Inc
|
1.92 | 43.52M | 35.16M | -11.44M | -15.44M | -0.5961 |
|
JBS
Jbs Nv
|
12.28 | 40.39B | 88.25B | 1.91B | -681.64M | 1.6761 |
|
KHC
Kraft Heinz Co
|
25.67 | 30.44B | 24.99B | -5.76B | 3.95B | -4.863 |
|
GIS
General Mills Inc
|
36.03 | 19.23B | 18.42B | -85.30M | 1.63B | -0.1894 |
|
HRL
Hormel Foods Corp
|
25.31 | 13.93B | 12.22B | 466.64M | 692.94M | 0.8477 |
|
MKC
Mccormick Co Inc
|
49.96 | 13.43B | 7.39B | 1.63B | 1.02B | 6.0085 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Roth Capital | Buy |
| May-05-25 | Initiated | Craig Hallum | Buy |
| Dec-18-24 | Initiated | Maxim Group | Buy |
Bioharvest Sciences Inc Stock (BHST) Latest News
Bioharvest Sciences Inc (BHST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bioharvest Sciences Inc (BHST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BHST|Bioharvest Sciences Inc|Price:1.920|Chg%:-0.080 - TradingKey
Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enterprise value to revenue forward of BioHarvest Sciences, Inc. – MUN:8MV0 - TradingView
Enterprise value to EBIT forward of BioHarvest Sciences, Inc. – DUS:8MV0 - TradingView
Market Sentiment Around Loss-Making BioHarvest Sciences Inc. (NASDAQ:BHST) - webull.com
Price to earnings forward of BioHarvest Sciences, Inc. – DUS:8MV0 - TradingView
BioHarvest Sciences Inc. (BHST) Declines 2.81% as Stock Tests Support Near $2.63Blue Chip Entry Points - dars.gov.et
BioHarvest Sciences (BHST) secures $1.4M Israel AI R&D funding - Stock Titan
BioHarvest Sciences (NASDAQ: BHST) secures $1.4M AI plant-cell research grant - Stock Titan
Market movers: Aehr Test Systems, BioHarvest Sciences, Dell, Century Lithium... - Proactive financial news
BioHarvest receives $1.4M grant for AI research platform By Investing.com - Investing.com Nigeria
BioHarvest Sciences secures $1.4M grant to boos... - Pluang
BioHarvest lands $1.4M grant for AI-driven plant science - Yahoo Finance
BioHarvest receives $1.4M grant for AI research platform - Investing.com
BioHarvest’s $1.4M grant targets AI that predicts plant-cell yields - Stock Titan
BioHarvest Sciences to Participate in the 'Health, Wellness & Longevity' Virtual Conference Presented by Maxim Group LLC - marketscreener.com
BioHarvest Sciences : to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC - marketscreener.com
BioHarvest CEO to speak at Maxim Health, Wellness & Longevity Conference - Proactive financial news
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC - TMX Newsfile
Bioharvest Sciences Inc (BHST) Institutional Confidence - TradingKey
BioHarvest Sciences Inc. Q1 2025 Earnings: Wider Loss per Share Misses Analyst ExpectationsCapex Guidance - dars.gov.et
BHSTBioHarvest Sciences Inc Latest SEC Filings - Finviz
BioHarvest Sciences (BHST) Rebounds 1.75% as Buyers Defend Key Support ZoneNAAIM Leverage - dars.gov.et
BioHarvest Sciences Inc. (BHST) Extends Gains, Tests Key Resistance at $3.06Overnight Profile - dars.gov.et
BioHarvest Sciences, Inc. Actuals & Estimates (MUN:8MV0) - TradingView
BioHarvest Sciences Inc. (BHST) reports Q1 loss, beats revenue estimates - MSN
BioHarvest Sciences, Inc. Actuals & Estimates (NASDAQ:BHST) - TradingView
8MV0 Forecast — Price Target — Prediction for 2027 - TradingView
BioHarvest Sciences, Inc. Actuals & Estimates (DUS:8MV0) - TradingView
BioHarvest Sciences, Inc. Actuals & Estimates (LS:A40C6G) - TradingView
Bioharvest Sciences Inc (BHST) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Miss Signals Continued Investment in GrowthEarnings Quality Score - dars.gov.et
BioHarvest Sciences to Showcase Botanical Synthesis at 2026 BIO International Convention - The Globe and Mail
BioHarvest Sciences (BHST) to showcase Botanical Synthesis at 2026 BIO Convention - Stock Titan
Bioharvest Sciences Inc (BHST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bioharvest Sciences Inc (BHST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioHarvest brings its plant-based tech to BIO International in San Diego - Stock Titan
BioHarvest Sciences to present botanical synthesis platform at BIO International Convention - Proactive financial news
BioHarvest Sciences to Present at the 2026 BIO International Convention - TMX Newsfile
Bioharvest Sciences Inc (BHST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bioharvest Sciences Inc (BHST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioHarvest Sciences Inc. Q1 2025 Earnings: EPS Misses Estimates Amid Operational ProgressRevenue Growth Report - dars.gov.et
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Miss Overshadows Steady ProgressReturn On Equity - dars.gov.et
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Misses Estimates as Company Continues Strategic AdvancementManagement Guidance Update - newsline.com
BHST PE Ratio & Valuation, Is BHST Overvalued - Intellectia AI
BioHarvest Sciences Q1 2025 Earnings: EPS Misses Estimates While Stock Sees Positive ReactionSegment Revenue Breakdown - newsline.com
BioHarvest Sciences Inc. (BHST) Advances 2.75% as Shares Hold Above Key SupportLong Setup Ideas - newsline.com
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: Higher Losses Weigh on Operational ProgressEarnings Preview - newsline.com
Bioharvest Sciences Inc Stock (BHST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):